एम्स (AIIMS ) की तरफ़ पहुँचती होम्योपैथिक चिकित्सा पद्दति

साभार : दैनिक हिन्दुस्तान दिनांक – २-११-२००९

(चित्र को बडे और साफ़ आकार मे देखने के लिये चित्र पर किल्क करें )

प्रधान्मंन्त्री स्वास्थ योजना के तहत स्थापित हो रहे ६ नये एम्स – AIIMS ( श्रषिकेश, पट्ना , रायपुर , भोपाल , जोधपुर और भुवनेशवर ) मे होम्योपैथिक चिकित्सा पद्दति की उपचार की सुविधा प्रदान की जायेगी । एम्स जैसे प्रीमयर संस्थानॊं मे आयुष पद्दति के लिये  ३० बेड का भी प्रावधान किया गया है ।

लखनऊ का नेशनल होम्योपैथिक कालेज – बुरे हाल ११ सालों मे भी न हो पाया पूरा निर्माण

साभार : दैनिक हिन्दुस्तान २८/८/२००९

चित्र को साफ़ देखने  के लिये  चित्र  पर  किल्क करें ।

नेशनल होम्योपैथिक मेडिकल कालेज ,गोमतीनगर ,  लखनऊ ( National Homeopathic Medical College, Lucknow)

ओ.पी.डी. -N.H.M.C. लखनऊ ( O.P.D.-N.H.M.C. Lucknow)

एक अत्याधुनिक  होम्योपैथिक अस्पताल की कल्पना सिर कागजों मे ही रह गयी । कालेज को अत्याधुनिक सुविधाओं से लैस करने  के उद्देशय से वर्ष १९९७  मे माननीय  अटल जी ने   इस  पाँच  मँजिला बिल्डंग का शिल्यानास किया था । लेकिन आज तक इसका पूरा निर्माण न हो पाया ,  पैसे की कमी का रोना तो मुख्य रहा ही लेकिन मुख्य  था  इच्छा शक्ति की कमी जिससे आये  धन को भी आला अधिकारियों ने कई बार वापस करवा दिया । लगभग ७००-८०० मरीजों की ओ.पी.डी. मे रोजाना उपस्थिति भी शासन को होम्योपैथी मे जनता के  बढते  विशवास को   जगा न सकी ।   इस नव  निर्मित अस्पताल मे १०० बेड  का होगा और  साथ मे  होगा दो आपरेशन  थिय़ेटर , ब्लड बैंक , गैस्ट्रोलोजी , पिडयाट्रिक्स और हड्डी के रोगियों को देखने  और  भरती करने  की विशेष  सुविधा । फ़िलहाल तो यह कागजो मे ही दिख रहा है ।                            

       

 

 

संबधित पोस्ट :

• लखनऊ का नेशनल होम्योपैथिक मेडिकल कालेज अब देश का पहला होम्योपैथिक विशवविधालय बनने की ओर अग्रसर
• धरा रह गया धन तो कैसे हो उत्तर प्रदेश मे होम्योपैथी का विकास !!
• एक और सरकारी तमाशे का बँटाधार- थमी मां-बच्चे की सेहत संवारने की होम्योपैथी मुहिम
• हिमाई ( HMAI ) की लखनऊ कान्फ़्रेन्स संपन्न

भूजल मे आर्सेनिक विषाक्तता– क्या होम्योपैथिक औषधि “ आर्सेनिक ऐलब्म “ आर्सेनिक प्रदूषित जल से उत्पन्न हुये रोगों की विकल्प औषधि होगी (Can Homeopathic Arsenic Remedy Combat Arsenic Poisoning in Humans Exposed to Groundwater Arsenic Contamination?: A Preliminary Report on First Human Trial )

साभार : आक्सफ़ोर्ड जर्नल (oxford journal )

 

चित्र को साफ़ और बडॆ आकार मे देखने के लिये चित्र पर किल्क करें ।

भूजल मे आर्सेनिक विषाक्तता – भारत जैसे करीब  बीस  देशों की एक त्रासदी ही है । पशिचम बंगाल और उससे सटे बाँगला देश के कई गाँवों के लोगों का जीवन आर्सेनिक संकर्मित जल ने भयकर रुप से रोगग्रसत कर दिया है । पूरे विशव मे करीब बीस मिलियन लोग इससे प्रभावित है , कई तरीकों से इससे उत्पन्न हुये रोगों से निजात पाने की चेष्टा की गयी लेकिन अभी तक कोई ठॊस परिणाम सामने नही आये हैं । आरेसेनिक संक्रमण से  त्वचा का कैन्सर , केरोटोसिस [keratoses] जैसी समस्यायें उत्पन्न हो सकती  हैं । आर्सेनिक विषाक्तता के अन्य लक्षणॊ  मे गर्दन में कडापन और जकड़न की भावना, प्यास, स्वर बैठना और बोलने  मे कठिनाई,  उल्टी हरे या पीले रंग के, कभी कभी खून से धारीवाले, मरोड के साथ दस्त, मूत्र अंगों मे कभी कभी तेज जलन और दर्द, और अंत मे मौत का कारण भी आरेसेनिक बन सकती है ।

  कल्याणी विशवविधालय और बिधन चन्द्र कृषि विशव्विधालय के शोधकर्ताओं जिनमे अनीसुर खुदाबक्श , सुजीत गुहा , नन्दिनी भट्टाचार्य आदि ने आरेसिन्क प्रदूषित जल से प्रभावित रोगियों पर होम्योपैथिक आरेसिन्क ३० का प्रयोग करके उससे उत्पन्न निष्कर्षो  को जानने की चेष्टा की और परिणाम बेहद उत्साहजनक निकले । उत्पन्न निष्कर्षो को जानने के लिये रोगियों को तीन माह तक आर्सेनिक ३० पर रख कर ईन्जाइम और रक्त के कई परीक्षण जैसे amino transferase, alanine amino transferase, acid phosphatase, alkaline phosphatase, lipid peroxidation और  reduced glutathione द्वारा  मानीटर किया गया ।

डाऊनलोड लिंक  (Download Link ):

                                                    Link 1

                                                    Link 2

Can Homeopathic Arsenic Remedy Combat Arsenic Poisoning
in Humans Exposed to Groundwater Arsenic Contamination?:
A Preliminary Report on First Human Trial
Anisur Rahman Khuda-Bukhsh1, Surajit Pathak1, Bibhas Guha1, Susanta Roy KarmakarJayanta Kumar Das1, Pathikrit Banerjee1, Surjyo Jyoti Biswas1, Partha Mukherjee,Nandini Bhattacharjee1, Sandipan Chaki Choudhury1, Antara Banerjee1, Suman Bhadra,Palash Mallick, Jayati Chakrabarti and Biswapati Mandal
Department of Zoology, University of Kalyani and
Directorate of Research, Bidhan Chandra Krishi Viswavidyalaya,
Kalyani-741235, West Bengal, India

Groundwater arsenic (As) has affected millions of people globally distributed over 20 countries. In parts of West Bengal (India) and Bangladesh alone, over 100 million people are at risk, but supply of As-free water is grossly inadequate. Attempts to remove As by using orthodox medicines have mostly been
unsuccessful. A potentized homeopathic remedy, Arsenicum Album-30, was administered to a group of As affected people and thereafter the As contents in their urine and blood were periodically determined. The activities of various toxicity marker enzymes and compounds in the blood, namely aspartate
amino transferase, alanine amino transferase, acid phosphatase, alkaline phosphatase, lipid peroxidation and reduced glutathione, were also periodically monitored up to 3 months. The results are highly encouraging and suggest that the drug can alleviate As poisoning in humans.

Download Link :

                                                   Link 1

                                                    Link 2

Keywords: arsenic toxicity – Arsenicum Album-30 – enzyme biomarkers – homeopathy –
human trial – remedy

स्वाइन फ़्लू , इन्फ़्लून्जियम और अन्य होम्योपैथिक औषधियाँ

मिनेटेस डाट काम पर शेरी ने इन्फ़्लून्जियम पर कुछ रोचक आँकडॆ दिये ।  1918 से 1957 तक इस औषधि के स्त्रोत फ़्लू से ग्रस्त रोगियों के नासिक स्त्राव और  रक्त के सैम्पल से लिये गये । और  इनमे से अधिकतर उन रोगियों से जो 1918 के फ़्लू की महामारी से ग्रस्त थे ।

1957 के बाद से दवा बनाने के  ढंग  मे बदलाव आया और दवा का स्त्रोत फ़्लू वैक्सीन से लिया गया । इग्लैंड की नेलसन होम्यो लैब इसकी मुख्य निर्माता और विक्रेता हैं और 1918 से 1957  अब तक लगभग 13 अलग –2 सैम्पल ला चुके हैं । इनमे से अधिकतर सैम्पल इसके पूर्व वर्ष मे हुये फ़्लू के वैक्सीन  से लिये गये हैं । 1918 का फ़्लू वाइरस मुख्यत: H1N1 वाइरस था और यह अब तक के सबसे अधिक खतरनाक वाइरस की श्रेणी मे आता है । होम्योपैथिक दृष्टिकोण से मुख्य है इसकी प्रूविग जिससे उत्पन्न लक्षण लगभग वही थे जो फ़्लू के लक्षण से मेल खाते थे । नेलसन द्वारा  उत्पादित इन्फ़्लून्जियम के अन्य उत्पाद निम्म हैं :

1. *Influenzinum (the 1918 epidemic) *
1. 2. Influenza virus A Asia /57
1. 3. Influenza virus A England 42/72
1. 4. Influenza virus B Hong Kong 5/72
1. 5. Influenza virus A/Port Chalmers 1/73
1. 6. Influenza virus A (Asian) 1954
1. 7. Influenza virus B (Asian) 1954
1. 8. Bacillus influenza 1918
1. 9. Influenza virus Az Hong Kong 1968
1. 10. Influenza virus Ar 1967
1. 11. Influenza virus B
1. 12. Influenza Co. (Combination of Az to 1918)
1. 13. Influenza virus a1.

नेलसन लैब के एम्सवर्थ ने इन उत्पादन पर अपनी कुछ इस तरह टिप्पणी की ,

"Our ‘Influenzinum’ is a nosode but it is old. pre 1985.
All the others are made from vaccines except 1989 and triple nosode.
As the flu strains vary from year to year we make up fresh potencies
from the years ‘most lightly flu’s’ vaccine each year in October".

लेकिन अपने देश मे कौन सा उत्पाद प्रयोग हो रहा है , इसके बारे मे दो प्रमुख कम्पनियाँ , बोइरोन इन्डिया और  श्वाबे इन्डिया ने भी अब तक कुछ खास जानकारी नही दी है ।

फ़्लू /स्वाइन /बर्ड /या आम फ़्लू से बचने के लिये इन्फ़्लूनिजियम प्रयोग करने का सही तरीका क्या है :

होम्योपैथिक दृष्टिकोण से  कोई फ़र्क नही पडता कि वह कौन सा फ़्लू है , स्वाइन / बर्ड / या आम फ़्लू , मुख्य है फ़्लू के लक्षणॊ का औषधि से मेल खाना  ।

इन्फ़्लूनिजियम नोसोड श्रेणी मे आता है और इसका व्यवहार भी  सावधानीपूर्वक करना चाहिये । इन्फ़्लूनिजियम 200 सपताह मे एक बार चार सप्ताह तक लगातार और इसके बाद महीने मे एक बार लें।

Influenzinum 200 c – take one dose every week for four weeks, and then, take the last dose one month later. This is intended as a strengthening/preventative measure

फ़्लू के लक्षण प्रकट होते ही किन औषधियों का प्रयोग करें :

• ओसिलोकोकिनम या ऐनस बार्ब 200c : फ़्लू की शुरुआत होते ही इसका प्रयोग करें । फ़िलहाल अपने देश मे उपलब्धता  नही के बराबर है ।

Oscillococcinum aka Anas Barb 200c. There are two names for this remedy. It’s Anas Barb in Nelsons. This is to be taken on the first onset of ‘flu symptoms. It should catch the early onset of the ‘flu. Though it’s not availbale in India .

• चुनी हुई सही चयनित औषधि : होम्योपैथिक औषधि प्रयोग करने का यह तरीका सबसे कारगर और सही है । फ़्लू हो जाने पर सही चयनित औषधि का चयन किसी कुशल होम्योपैथिक चिकित्सक से करवायें और प्रयोग करें । इससे संबधित इस लेख को भी देखें ।

The Indicated Remedy if you actually get the full blown ‘flu, then give the indicated ‘flu remedy according to the symptoms. Here’s a good guide: http://www.hpathy.com/diseases/Swine-flu-symptoms-treatment.asp

 आम प्रयोग होने वाली होम्योपैथिक औषधियाँ : लक्षण के अनुसार : [ मार्गेट टायेलेर की Pointers to the common Remedies देखें । ]

Aconite

Belladona

arsenic

Baptisia

Gelsemium

Eup Perf

Pyrogen

Bryonia

Rhus Tox

Mercurious

Camphor

Nux vom

AFTER INFLUENZA BADLY RECOVERED FROM

sulphur

china

arsenic

Cyprepedium pubescens

cyprepedin

Scutellaria lat

• "genus epidemicus”

[ चित्र को सफ़ और बडे आकार मे देखने के लिये किल्क करें ]

साभार : www.moleculardyne.com

माहामारियों मे दवा का चुनाव अन्य चुनाव की अपेक्षा आसान हो जाता है क्योंकि रोग के लक्षण लगभग एक से ही रह्ते हैं । और दवा का चुनाव  मुख्यत: एक या दो दवाओं पर आ टिकता  है ।  ऐसी अवस्था मे चयनित दवा को "genus epidemicus” कहते हैं । यही वजह थी कि 1918  के फ़्लू माहामारी मे होम्योपैथिक दवाओं से लाभ होने की संख्या अन्य पद्दतियों  की अपेक्षा कही अधिक थी ।

The indicated remedy in pandemics is usually very consistent and called the "genus epidemicus". This is narrowed down to a shortlist of three or less.

लेकिन क्या इन्फ़्लूजिनियम को "genus epidemicus” की श्रेणी मे डालना उचित है । हैनिमैन मुख्यत: इस तरह के चुनाव के पक्ष मे नही थे , कारण भले ही रोग का कारक एक ही हो लेकिन हर रोगी अपनी चारित्रिक विशेषताओं के होते हुये हर से भिन्न ही रहता है । "genus epidemicus” को लेकर हैनिमैन ने आर्गेनान मे कुछ विशेष निर्देश दिये हैं :

As per the guidelines laid down by Dr. Samuel Hahnemann in the Organon a Genus epidemics has to be found out in the specific area and it could be the best to be found out in the specific area and it could be the best prophylactic remedy.

    Source: ORGANON OF MEDICINE Aphorism 100-102

    § 100

    In investigating the totality of the symptoms of epidemic and sporadic diseases it is quite immaterial whether or not something similar has ever appeared in the world before under the same or any other name. The novelty or peculiarity of a disease of that kind makes no difference either in the mode of examining or of treating it, as the physician must any way regard to pure picture of every prevailing disease as if it were something new and unknown, and investigate it thoroughly for itself, if he desire to practice medicine in a real and radical manner, never substituting conjecture for actual observation, never taking for granted that the case of disease before him is already wholly or partially known, but always carefully examining it in all its phases; and this mode of procedure is all the more requisite in such cases, as a careful examination will show that every prevailing disease is in many respects a phenomenon of a unique character, differing vastly from all previous epidemics, to which certain names have been falsely applied – with the exception of those epidemics resulting from a contagious principle that always remains the same, such as smallpox, measles, etc.

    § 101

    It may easily happen that in the first case of an epidemic disease that presents itself to the physician’s notice he does not at once obtain a knowledge of its complete picture, as it is only by a close observation of several cases of every such collective disease that he can become conversant with the totality of its signs and symptoms. The carefully observing physician can, however, from the examination of even the first and second patients, often arrive so nearly at a knowledge of the true state as to have in his mind a characteristic portrait of it, and even to succeed in finding a suitable, homœopathically adapted remedy for it.

    § 102

    In the course of writing down the symptoms of several cases of this kind the sketch of the disease picture becomes ever more and more complete, not more spun out and verbose, but more significant (more characteristic), and including more of the peculiarities of this collective disease; on the one hand, the general symptoms (e.g., loss of appetite, sleeplessness, etc.) become precisely defined as to their peculiarities; and on the other, the more marked and special symptoms which are peculiar to but few diseases and of rarer occurrence, at least in the same combination, become prominent and constitute what is characteristic of this malady.1 All those affected with the disease prevailing at a given time have certainly contracted it from one and the same source and hence are suffering from the same disease; but the whole extent of such an epidemic disease and the totality of its symptoms (the knowledge whereof, which is essential for enabling us to choose the most suitable homœopathic remedy for this array of symptoms, is obtained by a complete survey of the morbid picture) cannot be learned from one single patient, but is only to be perfectly deduced (abstracted) and ascertained from the sufferings of several patients of different constitutions.

    1 The physician who has already, in the first cases, been able to choose a remedy approximating to the homœopathic specific, will, from the subsequence cases, be enabled either to verify the suitableness of the medicine chosen, or to discover a more appropriate, the most appropriate homœopathic remedy.

Homeopathic Individualized Q-potencies versus Fluoxetine for Moderate to Severe Depression: Double-blind, Randomized Non-inferiority Trial

Homeopathic Individualized Q-potencies versus Fluoxetine for
Moderate to Severe Depression: Double-blind, Randomized
Non-inferiority Trial

U. C. Adler, N. M. P. Paiva, A. T. Cesar, M. S. Adler, A. Molina, A. E. Padula
and H. M. Calil
Faculdade de Medicina de Jundiaı ´, Homeopathy Graduation Programme, Department of Psychobiology,
Universidade Federal de Sa ˜ o Paulo, Sa ˜ o Paulo, Brazi

Homeopathy is a complementary and integrative medicine used in depression, The aim of this study is to investigate the non-inferiority and tolerability of individualized homeopathic medicines [Quinquagintamillesmial (Q-potencies)] in acute depression, using fluoxetine as active control. Ninety-one outpatients with moderate to severe depression were assigned to receive an individualized homeopathic medicine or fluoxetine 20mg day–1(up to 40mg day–1) in a pro-
spective, randomized, double-blind double-dummy 8-week, single-center trial. Primary efficacy measure was the analysis of the mean change in the Montgomery & Asberg Depression Rating  Scale (MADRS) depression scores, using a non-inferiority test with margin of 1.45. Secondary  efficacy outcomes were response and remission rates. Tolerability was assessed with the side
effect rating scale of the Scandinavian Society of Psychopharmacology. Mean MADRS scores  differences were not significant at the 4th (P¼0.654) and 8th weeks (P¼0.965) of treatment.  Non-inferiority of homeopathy was indicated because the upper limit of the confidence interval (CI) for mean difference in MADRS change was less than the non-inferiority margin: mean differences (homeopathy–fluoxetine) were 3.04 (95% CI 6.95, 0.86) and 2.4 (95% CI 6.05, 0.77) at 4th and 8th week, respectively. There were no significant differences between the percentages of response or remission rates in both groups. Tolerability: there were no significant differences between the side effects rates, although a higher percentage of patients treated with fluoxetine reported troublesome side effects and there was a trend toward greater
treatment interruption for adverse effects in the fluoxetine group. This study illustrates the feasibility of randomized controlled double-blind trials of homeopathy in depression and indicates the non-inferiority of individualized homeopathic Q-potencies as compared to fluoxetine in acute treatment of outpatients with moderate to severe depression.

Keywords: depression – drug therapy – fluoxetine – homeopathy – integrative and
alternative medicine – non-inferiority – Q-potencies – randomized controlled trial – remission –
response

Source :

               http://ecam.oxfordjournals.org/ 

               www.drptandon.blogspot.com 

Download :

                      Link 1

                      Link 2

स्वाइन फ़्लू या शूकर इन्फ़्लूएंजा

शूकर इन्फ्लूएंजा, जिसे एच1एन1 या स्वाइन फ्लू भी कहते हैं, विभिन्न शूकर इन्फ्लूएंजा विषाणुओं मे से किसी एक के द्वारा फैलाया गया संक्रमण है। शूकर इन्फ्लूएंजा विषाणु (SIV-एस.आई.वी), इन्फ्लूएंजा कुल के विषाणुओं का वह कोई भी उपभेद है, जो कि सूअरों की महामारी के लिए उत्तरदायी है। 2009 तक ज्ञात एस.आई.वी उपभेदों में इन्फ्लूएंजा सी और इन्फ्लूएंजा ए के उपप्रकार एच1एन1 (H1N1), एच1एन2 (H1N2), एच3एन1 (H3N1), एच3एन2 (H3N2) और एच2एन3 (H2N3) शामिल हैं। इस प्रकार का इंफ्लुएंजा मनुष्यों और पक्षियों पर भी प्रभाव डालता है। शूकर इन्फ्लूएंजा विषाणु का दुनिया भर के सुअरो मे पाया जाना आम है। इस विषाणु का सूअरों से मनुष्य मे संचरण आम नहीं है और हमेशा ही यह विषाणु मानव इन्फ्लूएंजा का कारण नहीं बनता, अक्सर रक्त में इसके विरुद्ध सिर्फ प्रतिपिंडों (एंटीबॉडी) का उत्पादन ही होता है। यदि इसका संचरण, मानव इन्फ्लूएंजा का कारण बनता है, तब इसे ज़ूनोटिक शूकर इन्फ्लूएंजा कहा जाता है। जो व्यक्ति नियमित रूप से सूअरों के सम्पर्क में रहते है उन्हें इस फ्लू के संक्रमण का जोखिम अधिक होता है। यदि एक संक्रमित सुअर का मांस ठीक से पकाया जाये तो इसके सेवन से संक्रमण का कोई खतरा नहीं होता। 20 वीं शताब्दी के मध्य मे, इन्फ्लूएंजा के उपप्रकारों की पहचान संभव हो गयी जिसके कारण, मानव मे इसके संचरण का सही निदान संभव हो पाया। तब से ऐसे केवल 50 संचरणों की पुष्टि की गई है। शूकर इन्फ्लूएंजा के यह उपभेद बिरले ही एक मानव से दूसरे मानव मे संचारित होते हैं। मानव में ज़ूनोटिक शूकर इन्फ्लूएंजा के लक्षण आम इन्फ्लूएंजा के लक्षणों के समान ही होते हैं, जैसे ठंड लगना, बुखार, गले में ख़राश, खाँसी, मांसपेशियों में दर्द, तेज सिर दर्द, कमजोरी और सामान्य बेचैनी।

लक्षण

इस के लक्षण आम मानवीय फ़्लू से मिलते जुलते ही हैं – बुखार, सिर दर्द, सुस्ती, भूख न लगना और खांसी. कुछ लोगों को इससे उल्टी और दस्त भी हो सकते हैं. गंभीर मामलों में इसके चलते शरीर के कई अंग काम करना बंद कर सकते हैं, जिसके चलते इंसान की मौत भी हो सकती है.

मनुष्यों मे शूकर इंफ्लुएंजा के मुख्य लक्षण

 

 

बचाव

• मुँह और अपनी नाक को ढक कर रखें , खासकर तब जब कोई छींक रहा हो ।
• बार-बार हाथ धोना जरूरी है;
• अगर किसी को ऐसा लगता है कि उनकी तबीयत ठीक नहीं है तो उन्हें घर पर रहना चाहिये। ऐसी स्थिति में काम या स्कूल पर जाना उचित नहीं होगा और जहां तक हो सके भीड़ से दूर रहना फायदेमंद साबित होगा।
• अगर सांस लेने में तकलीफ होती है, या फिर अचानक चक्कर आने लगते हैं, या उल्टी होने लगती है तो ऐसे हालात में फ़ौरन डॉक्टर के पास जाना जरूरी है.

साभार : विकीपीडिया ( हिन्दी )

स्वाइन फ़्लू पर दो पावर पाइन्ट प्रेसन्टेन्शन को अवशय देखें , इसमे से एक डा. टी.वी. राव , प्रोफ़सर माइक्रोबाइलोजी , श्री देव राज मेडिकल यूनिवरसिटी , कोलार का , “ Swine flue outbreak 2009 “ है और दूसरा Homeopathy 4 everyone 2007 मे “ Homeopathy & the treatment of epidemic diseases “ नाम से प्रकाशित हुआ था ।

Swine flue outbreak 2009

डाउनलॊड लिंक : http://www.box.net/shared/uz79k46p0y

View this document on Scribd

Homeopathy & the treatment of epidemic diseases

डाउनलॊड लिंक : http://www.box.net/shared/y28k0rx1o5

View this document on Scribd

www.homeopathytorrents.blogspot.com – एक बेहतर माध्यम

Torrents शब्द पर भले ही कईयों को आपत्ति हो लेकिन बहुतों के लिये torrent sharing का उत्कृष्ट माध्यम है । www.homeopathytorrents.blogspot.com  होम्योपैथी चिकित्सकों और B.H.M.S. के छात्रों के लिये एक बेहतर शुरुआत है । यहाँ B.H.M.S. प्रथम वर्ष से लेकर अन्तिम वर्ष तक के छात्रों के लिये सब कुछ है जिसकी उनको आवशकता है , होम्योपैथी  मैटेरिया मेडिका , थेरापियूटिकस और   होम्योपैथी विषयों से जुडॆ पावर पाइन्ट प्रेसन्टेशन और शोध-पत्र और इसके अलावा होम्योपैथी से जुडॆ allied विषयों जैसे ऐनाटोमी , फ़िजोलोजी , प्रैकिटिस आफ़ मेडिसन , सर्जरी आदि के pdf और pdb फ़ार्मेट मे उपलब्ध पुस्तकें ।

 

विश्व होम्योपैथी समुदाय ( Homeopathic World Community )

चन्द  हफ्तों के अन्दर ही  विश्व  होम्योपैथी समुदाय का नेटवर्क दुनिया भर के ५४ देशों से ७५० होम्योपैथिक चिकित्सकों , छात्रों और होम्योपैथिक चिकित्सा पद्दति के प्रति रुझान रखने वालों के बीच लोकप्रिय हो चुका है । कम्यूनिटी का मुख्य उद्देशय होम्योपैथिक चिकित्सकों के बीच समन्वय और  सकारात्मक अनुभवों का आदान प्रदान करना है ।

होम्योपैथिक वर्ल्ड कम्यूनिटी मे शामिल होने केलिये http://www.homeopathyworldcommunity.com पर चटका लगायें ।

साभार : डॆबी ब्रुक

In six short weeks Homeopathy World Community Network has over 750 members representing 54 Countries around the world. Members are physicians and professional health providers who have years of training. Some are students presently taking degree programs at universities, colleges and certificate seminars around the world. Other members joined the movement to learn more after experiencing positive effects from homeopathy

Click HERE to join Homeopathic World Community

Courtesy : Debby Bruck

Dynamized Homeopathic Preparations in Cell Culture- a study report in Amala Cancer Research Centre, Kerala

Courtesy : Oxford Journal

Although reports on the efficacy of homeopathic medicines in animal models are limited, there are even fewer reports on the in vitro action of these dynamized preparations. In Amla Cancer Research Centre, Kerala , Ellanzhiyil Surendran Sunila, Ramadasan Kuttan, Korengath Chandran Preethi and Girija Kuttan have evaluated the cytotoxic activity of 30C and 200C potencies of ten dynamized medicines against Dalton’s Lymphoma Ascites, Ehrlich’s Ascites Carcinoma, lung fibroblast (L929) and Chinese Hamster Ovary (CHO) cell lines and compared activity with their mother tinctures during short-term and long-term cell culture. The effect of dynamized medicines to induce apoptosis was also evaluated and they have studied how dynamized medicines affected genes expressed during apoptosis. Mother tinctures as well as some dynamized medicines showed significant cytotoxicity to cells during short and long-term incubation. Potentiated alcohol control did not produce any cytotoxicity at concentrations studied. The dynamized medicines were found to inhibit CHO cell colony formation and thymidine uptake in L929 cells and those of Thuja, Hydrastis and Carcinosinum were found to induce apoptosis in DLA cells. Moreover, dynamized Carcinosinum was found to induce the expression of p53 while dynamized Thuja produced characteristic laddering pattern in agarose gel electrophoresis of DNA. These results indicate that dynamized medicines possess cytotoxic as well as apoptosis-inducing properties.

Recently, limited investigations on the efficacy of dynamized medicines in animal models as well as clinical trials have reported that potentiated Lycopodium clavatum has protective action against CCl₄-induced liver damage in rats (3) and that chelidonium 30C could ameliorate both p-dimethylaminoazobenzene and azodye-induced hepatocarcinogenesis in mice (4,5). Anti-genotoxic effect of different dynamized medicines has also been reported (6,7): Arsenicum album was found to ameliorate arsenic-induced toxicity in mice as well as in clinical studies and could reduce the elevated antinuclear antibody titer and hematological toxicities (8,9). Homeopathic therapy for asymptomatic HIV carriers has also proven beneficial (10) and recently Rajendran (11) reported homeopathy as a supportive therapy in cancer. Pathak et al. (12) investigated Ruta 6 on regression of human glioma brain cancer cell growth clinically and found that Ruta induces severe telomere erosion in MGRI brain cancer cells but has no effect on B-lymphoid cells and normal lymphocytes. Banerji and Banerji (13) reported that Ruta was effective for intracranial cysticercosis.

Very few investigations have explored the action of dynamized medicine in in vitro cell culture systems. Podophyllum has been shown to inhibit adhesion of neutrophils to serum-coated micro plates (14). Traumeen S, a homeopathic formulation used clinically to relieve trauma and inflammation has been shown to inhibit the production of Interleukin-β, TNF- and Interleukin-8 by human T cells and monocytes in culture (15). Many homeopathic drugs at low potencies were found to potentiate oxidative metabolism in cultured cells (16).

Medicines Used :

From होम्योपैथी नई सोच/ नई दिशायें

Results:

Although the healing potential of homeopathic drugs is widely accepted, the exact mechanism of action is still unclear. In paragraphs 63–69 of Organon, Hahneman describes the mechanism of action through the ‘primary action’ of the medicine (dynamized or not) and the ‘secondary and curative reaction’ of the organism: ‘Every agent that acts upon the vitality, every medicine, deranges more or less the vital force, and causes a certain alteration in the health of the individual for a longer or a shorter period. This is termed primary action. Although a product of the medicinal and vital powers conjointly, it is principally due to the former power. To its action our vital force endeavors to oppose its own energy. This resistant action is a property, is indeed an automatic action of our life-preserving power, which goes by the name of secondary action or counteraction’. We have tried to explain the mechanism of action of the dynamized preparations taking into consideration the original proposition by Samuel Hahnemann and have approached this problem by investigating the action of dynamized drugs in various cultured cells in a systematic scientific manner.

Cytotoxic activity of a drug is often considered a first step towards elucidating its possible use against cancer and all of the drugs selected are being used by homeopathic practioners against cancer. They have  found that in short-term cytotoxicity research, some of the dynamized preparations showed significant cytotoxic actions against cancer cell lines and at times the activity was higher than that of the mother tinctures. For example, Conium at 200C potency was more cytotoxic than its mother tincture and that the cytotoxicity induced by Carcinosinum was higher at 200C than at 30C potency indicating that dynamization induces the cytotoxic potential of these medications. Results were more pronounced during MTT assay in which a longer period of incubation was involved. Many dynamized preparations at potency of 200C inhibited the growth of L929 cells. Clonogenic assay using CHO cells is a standard method to determine growth inhibitory activity of the drugs and we found that dynamized preparations of Thuja, Hydrastis, Carcinosinum and Podophyllum at 200C potency almost completely inhibited the CHO colony formation. As in other cases, Conium 200C was more active than 30C. We have confirmed the cytotoxic potential of dynamized preparations by thymidine uptake, for the marker of the inhibition DNA synthesis. As in the case other experiments, DNA synthesis was significantly inhibited by several dynamized preparations.

Cytotoxicity could be produced in cells either by necrosis or by apoptotic induction. Apoptosis, which is known as programmed cell death is highly regulated by events taking place within the cell and is highly relevant with respect to the destruction and removal of transformed cells from the body. The induction of apoptosis could be an external agent and a cascade of reactions taking place within the cell produces an ultimate cell death. Some of the events via occurring during apoptosis include morphological changes in the cell, production of apoptotic bodies, damage to genetic material and finally induction of proteolytic enzymes, which produces cellular destruction. Apoptosis could be visualized by morphology and DNA laddering. In the present study, dynamized preparations induced apoptosis as observed from their morphology and DNA laddering. Moreover, dynamized preparation of Carcinosinum could induce the p53, which is considered to be a proapoptotic protein and involved in signal transduction pathway.

The mechanism of action of some of the homeopathic drugs has been proposed. Potentiated preparation of Ruta possesses protective action on normal B-lymphoid cells against H₂O₂-induced chromosomal damage (13). Moreover, the telomere erosion was enhanced in cancer cells by treatment with Ruta while normal cells showed no change. Thus, the telomeres that protect individual chromosomes of cancer cells are damaged by Ruta, which may be the mechanism of its therapeutic action in brain cancer (13).

The protective effect of Chelidonium against p-DAB-induced hepatic cancer may occur by the modulating effect of the drug on restoration of damage caused to several gene-regulated phenomena like enzyme activities and chromosomal abnormalities. This gives insight into the mechanism of action, which may be by means of interfering with the process of carcinogenesis by actively modifying actions of oncogenes or by activating tumor suppressor genes (5). Another mechanism of actions of homeopathic drugs may occur through immune modification. Benveniste (17) has shown that human basophils undergo degranulation not only at usual anti-IgE antibody doses but also at extremely high dilutions. Bastide (18)has shown the therapeutic effect of high dilution of –β interferon and thymic hormones on cellular immunity and had good therapeutic effect in immunodepressed patients. Similarly Bentwich et al. (19) revealed that small amounts of antigens are capable of specific antibody response. The role of immunity in the therapeutic efficacy of homeopathic medicines has also been reviewed (20).

There  results indicate that the dynamized preparation initially produces a secondary action on cells that is in line with the original proposition by Hahnemann on the mechanism of action of medicines dynamized or not. However, limited knowledge in this area does not fully explain the mechanism of action of all drugs . More scientific analyses are warranted to elucidate these interesting preparations of ultra dilutions.

Download full study report

in pdf : http://ecam.oxfordjournals.org/cgi/reprint/6/2/257

in text : http://ecam.oxfordjournals.org/cgi/content/full/6/2/257

Swiss take an holistic approach towards CAM

SWITZERLAND BECAME the first country in Europe to enshrine complementary medicine into its constitution when more than 67 per cent of national voters opted in favour of a new constitutional article on complementary medicine last week.

That result, which followed a public campaign, will now make it more likely that certain complementary therapies will be re-instated into the basic health insurance scheme available to all Swiss citizens.

Therapies including homeopathy, herbalism and traditional Chinese medicine were removed from the basic health insurance scheme in 2004 and put into additional optional private health insurance schemes.

The constitutional article on complementary medicine is also likely to speed up standardisation of training for complementary therapies in Switzerland. Currently, each canton regulates the complementary therapists within its region.

“The constitutional text itself is very short – it states that the Federal government and the cantons will ensure that, within the scope of their jurisdiction, complementary medicine is taken into consideration,” explains Alexander Harbaugh, a spokesman for the public campaign which brought the complementary medicine proposal to parliament.

In Switzerland, a new constitutional article can be proposed to the Swiss parliament if it is supported by 100,000 signatures gathered within 18 months.

In this case, the parliament rejected the initial proposal on complementary medicine and put forward its own counterproposal on complementary medicine which was then put to a vote.

A majority of citizens in all cantons voted in favour of adopting this new constitutional article. Historically, counter-proposals have been three times more likely to be voted in by the public than original popular proposals.

“It shows that we are beginning to come out of the two camps – one for orthodox medicine and the other for alternative medicine. In the future, hopefully, it will mean that medical students will study complementary therapies as part of their medical training and be able to integrate some of them into their practice,” says Harbaugh.

One of the aspirations of the pro-complementary therapy lobby group is that professorships of complementary medicine will now be created in Swiss universities.

“The parliament will decide what concrete measures will be taken on complementary medicine in the next few months,” says Mona Neidhart from the Swiss Federal Office of Public Health. She expects that the representative bodies of specified complementary therapies will submit new applications to gain approval for inclusion in the basic health insurance scheme.

“Complementary therapies can currently apply for inclusion in the basic health insurance scheme but up to now, they haven’t managed to be included. This vote will mean the parliament can change the criteria for inclusion,” explains Neid-hart.

The current criteria requires that the therapy benefits the patient, that it is cost-effective and appropriate for the patient’s condition.

Commenting on the vote, Daniel Kieffer, president of the European Association of Naturopathy, said naturopathy was already prominent although not widely accepted in Switzerland. “This vote puts naturopathy on the road to freedom and is a model for all other European countries,” he said.

Dutch pharmacist turned naturopath Jan de Vries worked for years with the Swiss naturopath, Alfred Vogel. He says Switzerland has a long tradition of homeopathy and herbal medicine. “A lot of regulatory work on complementary therapies has already been done in Switzerland and there is greater recognition for complementary therapists. I wish the same thing would happen in Germany because then other European countries could benefit from it,” he says.

De Vries, who has worked in Ireland for 40 years, says, “There is a great longing for natural medicine in Ireland. Irish people are very interested in finding out more about natural forms of medicine.”

In Ireland, the 2006 report of the National Working Group on Regulation of Complementary Therapies represents the current state of play in Ireland in this area.

This report recommended that statutory regulation be put in place for so-called high risk therapies.

These therapies are acupuncture, traditional Chinese medicine and herbalism. It recommended that practitioners of other complementary therapies form federations and self-regulate their practitioners and standardise their training courses. Therapies such as yoga and homeopathy currently follow this model.

Earlier this year, the Higher Education and Training Awards Council (HETAC) began the process of validating complementary therapy courses in acupuncture, herbal medicine and traditional Chinese medicine as the first step towards statutory regulation of these therapies.

Courtesy : Irish Times & I heal